Lyme Disease: Why the Delay in Human Vaccines?

Richard Marconi, PhD, professor of microbiology and immunology at Virginia Commonwealth University Medical Center, explains why there has been a holdup in the development of a new human Lyme disease vaccine.

The previous human vaccine was taken off the market because of unfounded concerns, but this had a significant impact on the interests of big pharma to develop a new vaccine. Now, he says, there is significant interest in taking Lyme disease vaccines forward in the human market.